Phoenix Tissue Repair

Phoenix Tissue Repair is a company specializing in the development of treatment for recessive dystrophic epidermolysis bullosa, a rare skin disease resulting from a deficiency of human collagen type VII. It develops PTR-01, a disease-modifying drug that is delivered intravenously to patients, replacing defective collagen type VII with healthy collagen at the sites where it is needed.